Skip to main content
Cochlear Limited (ASX: COH)
Australia flag Australia · Delayed Price · Currency is AUD
289.48
-1.45 (-0.50%)
Nov 7, 2024, 4:10 PM AEST

Cochlear Revenue

In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B AUD with 15.47% growth. Cochlear had revenue of 1.14B in the half year ending June 30, 2024, with 37.40% growth.

Revenue
2.24B
Revenue Growth
+15.47%
P/S Ratio
8.49
Revenue / Employee
442.96K
Employees
5,097
Market Cap
18.95B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20242.24B299.50M15.47%
Jun 30, 20231.94B287.80M17.46%
Jun 30, 20221.65B150.70M10.06%
Jun 30, 20211.50B177.00M13.40%
Jun 30, 20201.32B-106.10M-7.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 22.18B
ResMed Inc. 6.93B
Pro Medicus Limited 161.50M
Fisher & Paykel Healthcare Corporation Limited 1.60B
Sonic Healthcare Limited 8.97B
Ramsay Health Care Limited 16.66B
Telix Pharmaceuticals Limited 645.68M
Clarity Pharmaceuticals Ltd 11.51M
Revenue Rankings

Cochlear News

More News